Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort

Rheumatology (United Kingdom)

Volumn 53, Issue 6, 2014, Pages 1075-1086

  Arnold, Michael B ^a,b   Bykerk, Vivian P ^c,d   Boire, Gilles ^e   Haraoui, Boulos P ^f   Hitchon, Carol ^g   Thorne, Carter ^h   Keystone, Edward C ^c   Pope, Janet E ^a   Ahluwalia, Vandana ⁱ   Akhavan, Pooneh ⁱ   Arbillaga, Hector ⁱ   Baron, Murray ⁱ   Bell, Mary ⁱ   Bensen, William ⁱ   Cividino, Alf ⁱ   Colmegna, Ines ⁱ   Jamal, Shahin ⁱ   Kinkhoff, Alice ⁱ   Kraishi, Majed ⁱ   Larche, Maggie ⁱ   Lyddell, Chris ⁱ   Menard, Henri ⁱ   Mosher, Dianne ⁱ   Nair, Bindu ⁱ   Norris, Erin ⁱ   Penney, Chris ⁱ   Rubin, Laurence ⁱ   Shaw, Emily ⁱ   Sutton, Evelyn ⁱ   Zummer, Michel ⁱ   more..

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF TORONTO   (Canada)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f Institut de Rhumatologie de Montreal   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h ANIMAL HEALTH TRUST   (United Kingdom)

ⁱ Department of Rheumatology St Joseph's Health Care School of Medicine and Dentistry University of Western Ontario ^*

Author keywords

ACPA; Age; CATCH cohort; DMARDs; ERA (early RA); Predictors of outcome; Remission; RF; Sex

Indexed keywords

BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DAS28; DISEASE DURATION; EROSION; FEMALE; GROUPS BY AGE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; CANADA; COHORT STUDIES; COMORBIDITY; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900835248     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket449     Document Type: Article

References (58)

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
2. Young A, Dixey J, Cox N et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology 2000;39: 603-11.
3. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26:2529-33.
4. Pincus T, Callahan LF, Sale WG et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
5. Haraoui B, Pope J. Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum 2011;40: 371-88.
6. Breedveld F. The value of early intervention in RA-a window of opportunity. Clin Rheumatol 2011;30(Suppl 1): S33-9.
7. Resman-Targoff BH, Cicero MP. Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. Am J Manag Care 2010;16(Suppl):S249-58.
8. Fleischmann RM, Stern RL, Iqbal I. Treatment of early rheumatoid arthritis. Mod Rheumatol 2005;15:153-62.
9. Imanaka T, Shichikawa K, Inoue K et al. Increase in age at onset of rheumatoid arthritis in Japan over a 30 year period. Ann Rheum Dis 1997;56:313-6.
10. Ma MH, Ibrahim F, Walker D et al. Remission in early rheumatoid arthritis: predicting treatment response. J Rheumatol 2012;39:470-5.
11. Camacho EM, Verstappen SM, Lunt M et al. Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Care Res 2011;63:1745-52.
12. Graell E, Vazquez I, Larrosa M et al. Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up. Clin Exp Rheumatol 2009;27: 284-91.
13. Burmester GR, Ferraccioli G, Flipo RM et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 2008;59: 32-41.
14. Verstappen SM, Jacobs JW, Huisman AM et al. Functional Health Assessment Questionnaire (HAQ) and Psychological HAQ are associated with and predicted by different factors in rheumatoid arthritis. J Rheumatol 2007; 34:1837-40.
15. Mancarella L, Bobbio-Pallavicini F, Ceccarelli F et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol 2007;34:1670-3.
16. Kuiper S, van Gestel AM, Swinkels HL et al. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001;28:1809-16.
17. Peltomaa R, Leirisalo-Repo M, Helve T et al. Effect of age on 3 year outcome in early rheumatoid arthritis. J Rheumatol 2000;27:638-43.
18. Uhlig T, Smedstad LM, Vaglum P et al. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of followup. Rheumatology 2000;39:732-41.
19. Mottonen T, Paimela L, Leirisalo-Repo M et al. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with ''sawtooth'' strategy. Ann Rheum Dis 1998; 57:533-9.
20. van Schaardenburg D, Breedveld FC. Elderly-onset rheumatoid arthritis. Semin Arthritis Rheum 1994;23: 367-78.
21. van Schaardenburg D, Hazes JM, de Boer A et al. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20: 45-52.
22. Leigh JP, Fries JF. Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:581-7.
23. van der Heijde DM, van Riel PL, van Leeuwen MA et al. Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis. J Rheumatol 1991;18: 1285-9.
24. Scott DL, Symmons DP, Coulton BL et al. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108-11.
25. Sherrer YS, Bloch DA, Mitchell DM et al. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986; 29:494-500.
26. Kaarela K. Prognostic factors and diagnostic criteria in early rheumatoid arthritis. Scand J Rheumatol Suppl 1985; 57:1-54.
27. Naz SM, Farragher TM, Bunn DK et al. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum 2008;58:985-9.
28. Pease CT, Bhakta BB, Devlin J et al. Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors. Rheumatology 1999;38:228-34.
29. Deal CL, Meenan RF, Goldenberg DL et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985;28:987-94.
30. Verstappen SM, Lunt M, Bunn DK et al. In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register. Ann Rheum Dis 2011;70: 1428-32.
31. Forslind K, Hafstrom I, Ahlmen M et al. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66:46-52.
32. Gossec L, Dougados M, Goupille P et al. Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 2004;63: 675-80.
33. Papadopoulos IA, Katsimbri P, Alamanos Y et al. Early rheumatoid arthritis patients: relationship of age. Rheumatol Int 2003;23:70-4.
34. Combe B, Cantagrel A, Goupille P et al. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol 2003; 30:2344-9.
35. Combe B, Dougados M, Goupille P et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum 2001; 44:1736-43.
36. Holmqvist M, Wolfe F, Michaud K. Diabetes in rheumatoid arthritis: incidence and association with RA treatment. Berlin: EULAR, 2012.
37. (NEAR) NoEAR. Canadian Early Arthritis Cohort (CATCH): A prospective cohort study of adults with new-onset inflammatory arthritis symptoms studied by the Network of Early Arthritis Researchers (NEAR). NEAR Protocol for Ethics Submission, 2007.
38. Toussirot E. Predictive factors for disability as evaluated by the health assessment questionnaire in rheumatoid arthritis: a literature review. Inflamm Allergy Drug Targets 2010;9:51-9.
39. Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569-81.
40. Felson DT, Smolen JS, Wells G et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011; 63:573-86.
41. Aletaha D, Ward MM, Machold KP et al. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005;52: 2625-36.
42. Goodson NJ, Farragher TM, Symmons DP. Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis. J Rheumatol 2008;35: 945-9.
43. van Zeben D, Hazes JM, Zwinderman AH et al. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993;20: 1288-96.
44. Linde L, Sorensen J, Ostergaard M et al. What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire? J Rheumatol 2009;36: 2183-9.
45. Machold KP, Stamm TA, Nell VP et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology 2007;46: 342-9.
46. Morel J, Combe B. How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005; 19:137-46.
47. Skapenko A, Prots I, Schulze-Koops H. Prognostic factors in rheumatoid arthritis in the era of biologic agents. Nat Rev Rheumatol 2009;5:491-6.
48. Sokka T, Willoughby J, Yazici Y et al. Databases of patients with early rheumatoid arthritis in the USA. Clin Exp Rheumatol 2003;21(Suppl 31):S146-53.
49. McCollum L, Pincus T. A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis. Rheum Dis Clin North Am 2009;35: 699-712, v.
50. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991;18:1298-306.
51. Anderson JK, Zimmerman L, Caplan L et al. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-joint counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index 5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score with ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res 2011;63(Suppl 11):S14-36.
52. Aga AB, Lie E, Uhlig T et al. Clinical predictors of response to methotrexate treatment in dmard naive patients with early rheumatoid arthritis: results from a longitudinal observational study. Berlin: EULAR, 2012.
53. Rupp I, Boshuizen HC, Roorda LD et al. Poor and good health outcomes in rheumatoid arthritis: the role of comorbidity. J Rheumatol 2006;33:1488-95.
54. van der Heijde DM, van Riel PL, van Leeuwen MA et al. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective followup study of 147 patients. Br J Rheumatol 1992;31:519-25.
55. Tutuncu Z, Reed G, Kremer J et al. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 2006;65:1226-9.
56. Kvien TK, Uhlig T, Odegard S et al. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci 2006;1069:212-22.
57. Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adultonset lupus: a meta-analysis. Lupus 2011;20:1345-55.
58. Aletaha D, Machold KP, Nell VP et al. The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey. Rheumatology 2006;45:1133-9.